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Semen Analysis – What  
a Clinician Should Know
Kevin Ka-Wai Lam, BSc, PhD; Raymond Hang-Wun Li, MBBS,FRCOG, FHKAM (O&G); Ernest Hung-Yu Ng, MBBS, MD, FRCOG; Pak-Chung Ho, MBBS, MD, FRCOG; 
William Shu-Biu Yeung, BSc, PhD
INTRODUCTION
?n?ertility is de?ned as ?ailure to achieve 
pregnancy after one year of regular 
unprotected intercourse? ?t is a signi?-
cant global problem with a prevalence 
of approximately 1 in 7 couples.1 Male 
factor is a common diagnostic catego-
ry, and as a single factor it accounts 
for approximately 20% of the infertile 
couples.2, 3
Semen analysis provides information 
on sperm production from the seminifer-
ous tubules. The parameters determined 
in a semen analysis serve as surrogate 
markers of reproductive function of the 
male partner. Although the value of the 
conventional semen analysis in the diag-
nosis of male infertility has been ques-
tioned in a number of studies,4 semen 
analysis when being done correctly can 
provide useful information for manage-
ment of infertile couples.
There are four objectives in this arti-
cle. The ?rst is to provide information that 
the patients should know on collection 
of semen. The second is to discuss the 
method used for the semen analysis and 
the reference ranges for various semen 
parameters. The third is to summarize the 
relationship between semen quality and 
reproductive outcome in the literature. 
The fourth is to share the experience of 
Queen Mary Hospital in Hong Kong in us-
ing sperm parameters for management of 
infertile couples.
SEMEN SAMPLE COLLECTION 
A proper semen analysis starts from ap-
propriate semen collection. Clinicians 
should give clear instructions on the 
method of semen collection to their pa-
tients. These include:
1.  The need of sexual abstinence from 
2 to 7 days.5 Prolonged abstinence 
may increase the sperm concentra-
tion and ejaculate volume; while the 
sperm concentration may decline if 
the abstinence period is too short.6
2.  Semen should be collected wholly in 
sterile and non-toxic container prefer-
ably provided and tested by the clinic 
or laboratory performing the analy-
sis. The early portion of the ejaculate 
contains mainly of the prostatic se-
cretion and is rich in sperm, while the 
later portions are mostly secretion 
from the seminal vesicle.7 Incomplete 
collection will affect the reliability of 
the result and should be reported to 
the laboratory, especially when the 
earlier part of the ejaculate is lost.
3.  The ejaculate should be produced by 
masturbation preferably in a semen 
collection room adjacent to the labo-
ratory. Stress affects semen parame-
ters.8 For men experiencing stress in 
Semen Analysis Provides Information on Sperm Production from the Seminiferous 
Tubules.
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the clinic, the semen can be collect-
ed at home but should be delivered 
to the laboratory within one hour. Pa-
tients should be told not to store the 
semen in the fridge to keep it ‘fresh’. 
During transport, the sample has to 
be kept at body temperature by plac-
ing the sample close to the body. 
4.  Commercial condoms for contracep-
tion should not be used for semen 
collection for diagnostic or thera-
peutic purpose. There are specially 
designed condoms without lubricant 
and spermicide for semen collection. 
It should be noted that some of the 
condoms marketed as non-spermici-
dal are in fact toxic to sperm.9 Prop-
er testing on the products should be 
conducted before recommending to 
patients.
5.  For men with febrile illness, sam-
ples should be submitted at least 3 
months after recovery.10
The laboratory staff should check 
against a checklist when receiving the 
semen sample (Table 1).
REFERENCE RANGES
The procedure described by the World 
Health Organization (WHO) in the ‘WHO 
laboratory manual for the examination 
and processing of human semen’ is 
generally regarded as the gold stand-
ard for performing semen analysis. 
The reference ranges suggested in the 
previous versions of the manual were 
criticized on their usefulness and lack 
of evidence.11 WHO addressed the con-
cerns in the recent edition of the manual 
published in 2010.5 In this latest edition, 
the reference ranges were derived from 
data of over 4,000 recent fathers recruit-
ed in several cross sectional studies of 
semen analysis collected from fertile 
populations in Europe, America, Asia 
and Australia; these men became fathers 
within 12 months after stopping contra-
ception.12 The ?fth centile of semen vol-
ume, sperm count, motility, vitality, and 
morphology were considered as the 
lower reference limits (Table 2). Nomen-
clature for semen variables were also 
included (Table 3).
Caution should be exercised when 
interpreting the reference range. As the 
reference ranges are derived from re-
cent fathers, it is important to be aware 
that men with semen parameters that 
fall below the limits are not necessari-
ly infertile nor have a lower probability 
of fathering a child. On the other hand, 
 Table 1. Checklist for Receiving Semen Sample
Checklist
- To check the patient identity document
- To check the semen collection bottle identity label
-  To check if the following information is recorded in the semen submission 
form:
• Date, time and place of sample collection
• Duration of abstinence
• Method of sample collection
• Complete/incomplete collection
• Any anomalies in collection and/or transportation
• Patient signature
 Table 2. Lower Reference Limits (WHO 2010) and Reference Value (WHO 1999)  
for Semen Characteristics




Semen Volume 1.5 ml ? 2.0 ml
Sperm Concentration 15 million sperm/ ml ? 20 million sperm/ ml
Progressive Motility 32% ? 50%*
Total Motility 40%^ n/a
Vitality 58% live ? 75% live
Morphology (Strict criteria) 4% normal form (? 15% normal form)#
*Grade a + b according to the WHO 1999 manual.
^Progressive motile + non-progressive motile sperm according to the WHO 2010 manual.
#No actual value given. Value was concluded from multi-centre studies.
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men with semen parameters above 
the limits do not guarantee fertility be-
cause semen analysis does not directly 
measure sperm fertilizing potential. A 
signi?cant portion of men with defective 
sperm-zona pellucida interaction and 
therefore failure of fertilization in IVF 
can have normal semen parameters.13 
Moreover, these reference values are 
valid only when the protocols stated in 
the manual are followed. Due to consid-
erable overlap of semen parameters be-
tween fertile and infertile populations,14 
diagnosis of the fertility potential of men 
should be made by combining the re-
sults of semen analysis, medical history 
and fertility history. 
SEMEN ANALYSIS 
PROCEDURES
In the laboratory, a semen analysis be-
gins with physical examination of the 
sample including determination of pH, 
volume, viscosity and visual appear-
ance of the sample. Semen is ejaculated 
as coagulum, and should liquefy within 
60 minutes.5 The clinical signi?cance 
of delayed liquefaction remains contro-
versial. Semen volume is measured by 
a graduated pipette or by weight when 
the semen is collected in a pre-weighted 
specimen container, assuming the den-
sity of semen to be 1g/mL.5 Semen pH 
is measured by pH paper, and it tends 
to increase with time. There is no reliable 
reference range for semen pH, and WHO 
used the consensus value of 7.2 as the 
lower reference range.5 Semen viscosity 
is assessed by estimating the length of 
the thread formed when releasing a drop 
of semen from a pipette. Viscous seminal 
plasma impairs accurate measurement 
of sperm motility.
The main sperm parameters to be 
determined are motility, concentration, 
morphology and vitality. Sperm concen-
tration is measured by volumetric dilu-
tion and hemocytometric counting of the 
sperm. The new edition of the manual 
classi?es sperm motility into ‘progres-
sively motile’, ‘non-progressively motile’ 
and immotile,5 instead of the four cate-
gories de?ned in the earlier versions. 
Sperm with forward motion or moving in 
large circles are de?ned as having pro-
gressive motility, while those with other 
patterns of motion without any progres-
sion as having non-progressive motility. 
Computer-aided sperm analysis sys-
tems are not recommended for routine 
semen analysis because some of the 
systems cannot accurately distinguish 
sperm from debris in the semen and spe-
cial quality control procedures including 
specimen preparation are required to 
provide high quality results.
The ?fth edition of the manual rec-
ommends the use of the Tygerberg strict 
criteria5 for assessing the percentage of 
sperm with normal morphology. The size 
and structure of the head, mid-piece, tail 
and cytoplasmic droplet of each sperm 
are assessed. Only spermatozoa with-
out any morphological abnormalities of 
all components are classi?ed as normal. 
Sperm vitality determination is clinically 
important if a large proportion of sper-
matozoa are immotile because immotile 
sperm are not necessarily dead though 
motile sperm must be viable. Sperm vi-
tality is assessed by dye exclusion test; 
dead cells, but not viable sperm with an 
intact membrane, will take up the dye.
There is no universally accepted 
method for assessment of antisperm 
antibodies. The clinical evidence for its 
use in prediction of natural conception 
and assisted reproduction outcome is 
thin, and a recent systematic review and 
meta-analysis showed that semen an-
tisperm antibodies are not related to IVF 
and ICSI outcome.15 The National Insti-
tute for Clinical Excellence (NICE) does 
not recommend routine screening of an-
tisperm antibodies.16
 Table 3. Nomenclature for Semen Variables (WHO 2010)
Aspermia No semen
Asthenozoospermia Percentage of progressively motile sperm 
< 32%
Azoospermia No spermatozoa in the ejaculate
Normozoospermia Normal ejaculates with parameters above 
the lower reference limit
Oligoasthenoteratozoospermia Sperm concentration and percentage 
of progressively motile sperm and 
morphologically normal sperm below the 
lower reference limit
Oligozoospermia Sperm concentration fewer than 15 million / ml
Teratozoospermia Percentage of morphologically normal 
sperm fewer than 4%
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OTHER SPERM  
FUNCTION TESTS
Routine semen analysis gives no clue 
about the fertilizing activities of sperm. 
A number of sperm function tests have 
been developed. For instance, the hem-
izona binding assay is used to deter-
mine the zona pellucida binding ability 
of sperm.17 Sperm acrosome reaction 
can be evaluated by the acrosome re-
action-ionophore challenge test.18 De-
spite the potential predictive value of the 
sperm function tests on IVF outcome, 
these tests are used for research purpos-
es mainly due to the complexity of the 
tests and the need of expertise for their 
interpretation.
Sperm DNA integrity tests refer to a 
panel of tests using different methodolo-
gies to measure the extent of DNA dam-
age in sperm. There is no consensus on 
the reference values of results derived 
from the various methodologies. The 
association of the test results with repro-
ductive outcome in studies is con?icting. 
The Special Interest Group in Andrology 
of the European Society of Human Re-
production and Embryology questioned 
the validity of some of the test protocols 
as they might induce DNA damage.19 The 
American Society for Reproductive Med-
icine does not recommend the tests for 
routine clinical use.20
VARIATION OF SEMEN 
PARAMETERS
There is no well-de?ned semen parame-
ter that distinguishes infertile from fertile 
men. This is partly due to the fact that the 
parameters determined in a convention-
al semen analysis are not directly meas-
uring the function of sperm in fertilizing 
an oocyte. In addition, semen parame-
ters are known to vary widely between 
samples from the same man. The varia-
tions are derived from two sources. The 
?rst source is the inherent ?uctuation of 
the semen parameters within the same 
men. Many conditions such as duration 
of abstinence, illness and activity of ac-
cessory sex glands affect the semen 
parameters. Therefore, semen analysis 
is recommended to be performed on at 
least two samples collected 2 to 4 weeks 
apart to obtain representative results.5 
However, multiple semen analyses to 
further compensate for the variation may 
not be cost-effective. In an assisted re-
production program, clinical evaluation 
does not necessarily require analysis of 
multiple samples. NICE recently recom-
mended that a second semen analysis 
is required only if the result of the ?rst 
sample is abnormal.16 Single-off semen 
analyses are generally predictive of fer-
tility problem in cases of extreme severe 
semen abnormality or azoospermia.
The second source of variation 
originates from the laboratories. There 
are wide variations in the protocols used 
and the technical standard of laborato-
ries performing semen analysis,21 result-
ing in large inter-laboratory variation of 
the semen analysis parameters. In a sur-
vey in United Kingdom, only 5% of the 
laboratories followed all the WHO guide-
lines.22 There are also variations among 
technicians within the same laboratory. 
Most of the semen analysis procedures 
are done manually and some, such as 
morphology assessment, depend on 
subjective judgment. Training can re-
duce the variation among technicians.23 
Therefore, semen analysis should 
ideally be performed by experienced 
technicians in a dedicated andrology 
laboratory with internal and external 
quality control. Internal quality control 
and standard operation procedure are 
important to standardize and stabilize 
the manual process of semen analysis. 
In this regard, WHO recommends lab-
oratories to set up their own reference 
ranges. Participation in external quality 
control will help to compare results from 
different laboratories.
SEMEN QUALITY AND 
NATURAL CONCEPTION
A number of reports studied the rela-
tionship between semen parameters 
and natural conception. No single se-
men parameter is predictive of natural 
conception. Bonde et al. (1998) studied 
the semen parameter of 430 ?rst-preg-
nancy planners, and concluded that the 
probability of conception increased with 
sperm concentration up to 40×106/mL, 
above which the chance of conception 
increased with increase in percentage of 
sperm with normal morphology.24 Semen 
volume and motility were not predictive. 
Guzick et al. (2001) compared the semen 
parameters of 765 infertile and 696 fertile 
couples.14 There were extensive overlaps 
in the semen parameters between the 
two populations. None of these param-
eters was a good discriminator, but mor-
phology had the greatest discriminatory 
power. The available data suggest that 
the chance of pregnancy increases with 
increasing numbers of motile sperm with 
normal morphology in the ejaculate.
There is no well-de?ned semen parameter  
that distinguishes infertile from fertile men
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SEMEN QUALITY  
AND INTRAUTERINE 
INSEMINATION (IUI)
Available reports suggest that male 
factors affect IUI outcome, though well 
conducted randomized controlled trials 
is lacking limiting the quality of the ev-
idence. Wainer et al. (2004) retrospec-
tively analyzed 2,564 IUI cycles, and 
showed improved pregnancy rates when 
the numbers of motile sperm inseminat-
ed were above 5×106 and the percent-
age of sperm with normal morphology 
exceeded 30%.25 Ombelet et al. (1997) 
examined 792 IUI cycles and conclud-
ed that a combination of an inseminated 
motile sperm concentration below 1×106 
and a normal morphology less than 4% 
predicted failure.26 There is no consen-
sus on a threshold of semen parameters 
above which IUI may be offered. Many 
authors agreed that a minimum total mo-
tile sperm count of 1×106 sperm after 
sperm preparation are required to obtain 
satisfactory outcome.27, 28
SEMEN QUALITY AND IN 
VITRO FERTILIZATION (IVF) /
INTRACYTOPLAMSIC SPERM 
INJECTION (ICSI)
Sperm quality is only one of the many con-
founding variables affecting the outcomes 
of IVF/ICSI. This together with variation in 
IVF/ICSI practice among assisted repro-
duction centres makes it dif?cult to com-
pare studies and to isolate the in?uence 
of sperm quality on the treatment out-
comes. Despite lack of evidence-based 
consensus on the relationship between 
sperm parameters and outcomes, some 
generalization on using semen quality as 
guidance for treatment path of the subfer-
tile couples is agreed upon. 
1.  ICSI is required for extremely poor 
semen quality.
a.  Azoospermia or severe oligozoo-
spermia.
Azoospermia is de?ned as no sperm 
seen under low power microscopic ex-
amination of the sediment after centrifu-
gation of the semen sample.5 The preva-
lence is about 1% in the male population, 
and ranges between 10-15% of infertile 
men.29 Azoospermic men with low sem-
inal pH (<7.0) and volume (<1.0 mL) 
may suggest congenital bilateral ab-
sence of the vas deferens (CBAVD) or 
ejaculatory duct obstruction.30, 31 There 
is no consensus cutoff value for severe 
oligozoospermia. When azoospermic 
or severe oligozoospermic results were 
encountered, additional tests should be 
performed to diagnose the cause of the 
conditions. These tests include physical 
examination of the male reproductive 
tract, determination of serum testoster-
one and follicle stimulating hormone (to 
distinguish between hypogonadotroph-
ic hypogonadism, testicular failure and 
obstructive causes), and genetic tests 
such as karyotype and Y-chromosome 
microdeletion.32 In Hong Kong, the prev-
alence of chromosomal abnormalities 
and Y-chromosome micro-deletion is 
10.5% and 8.3%, respectively for men 
with sperm count <2×106/mL and azo-
ospermia.33 Mutation of cystic ?brosis 
transmembrane conductance regulator 
gene should be checked for in Cauca-
sian men with CBAVD. Microsurgical 
retrieval of sperm with ICSI and use of 
donor sperm are the treatment options.
b. Globozoospermia
This refers to presence of only sperm 
with round head in morphological as-
sessment. The prevalence of men with 
total or partial globozoospermia is less 
than 0.1% in infertile males.34 Round 
headed sperm usually have no or a small 
acrosome,35 an organelle required for 
fertilization. Therefore, globozoospermic 
men have fertilization problem. Fertiliza-
tion can be achieved using ICSI, though 
with lower fertilization rate.34
c. Immotile sperm
Kartagener’s syndrome is a rare genet-
ic disorder with an overall incidence of 
about 1/40,000.36 The disease affects the 
ciliary structure of the sperm tail, thus 
producing viable but immotile sperm. 
ICSI is currently the only treatment op-
tion of infertility for these men.
2.  Couples who fail in IUI and those 
who fail to meet the sperm quality 
requirements for IUI should be of-
fered IVF. The British Fertility Society 
recommend that IVF should be used 
when less than 5×106 motile sperm 
are recovered in a ‘diagnostic sperm 
preparation’ procedure.37
3.  Couples requiring surgical sperm 
retrieval from epididymis or testes, 
having severe asthenozoospermia 
(no consensus threshold) or severe 
teratozoospermia (no consensus 
threshold) or a combination of se-
vere oligo-astheno-teratozoospermia 
and those having failed fertilization or 
low fertilization rate (no consensus 
threshold) in previous IVF treatment 
should be offered ICSI.16
There are controversies on the use 
of sperm morphology as predictor of 
assisted reproduction outcome. While 
a positive correlation of fertilization rate 
and pregnancy rate with percentage of 
normal morphology using the strict cri-
teria was found in some studies,38, 39 no 
correlation was found in other studies. A 
recent meta-analysis40 showed that iso-
lated teratozoospermia was not associat-
ed with reduced IVF/ICSI outcome. The 
discrepancies in the results are probably 
due to subjectivity of assessing sperm 
morphology.
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INTERPRETATION AND 
PATIENT MANAGEMENT  
IN QUEEN MARY HOSPITAL, 
HONG KONG (CHART 1)
In Queen Mary Hospital, Hong Kong, 
semen analysis is performed by three 
experienced technical staff. Compliance 
to standard operation procedures and 
internal quality control program ensures 
semen analyses are performed accord-
ing to the WHO 2010 protocols with min-
imal variability in time and among staff. 
The andrology laboratory also joins the 
pro?ciency testing program of the Col-
lege of American Pathologists 41 to con-
?rm that the laboratory performance is in 
agreement with other laboratories in the 
program.
As interpretation of semen parame-
ters is laboratory speci?c, we always ask 
our patients to perform semen analysis 
in our own laboratory. Action is not taken 
simply based on mild subnormal semen 
parameters alone in men without history 
of infertility, except in extreme conditions 
such as azoospermia, globozoospermia 
and totally immotile sperm.
In general, IUI is advised as a ?rst 
line treatment for young subfertile cou-
ples (female age <35) with normal or 
mild male factor, bilateral patent tubes 
and normal ovulation. For couples who 
fail IUI or with morphologically normal 
sperm > 2% and more than 0.2×106 
motile sperm recovered in a ‘diagnostic 
sperm preparation’ procedure will be 
advised for IVF with conventional insem-
ination.
Our unpublished experience showed 
that the percent of morphologically nor-
mal sperm below 5% according to WHO 
1999 criteria42 were associated with de-
creased fertilization rate and pregnancy 
rate, and that ICSI could help to improve 
the outcome. Recent study also demon-
strated that sperm morphology by strict 
criteria positively correlated with the 
hemizona binding assay, zona-induced 
acrosome reaction and negatively with 
sperm chromatin packaging assay.43 
Our current practice is to perform ICSI for 
men with sperm morphology of ? 2% by 
strict criteria, which is roughly equivalent 
to 5% by WHO 1999 criteria according 
to our unpublished internal correlation 
study.
CONCLUSION
Despite the limitation of conventional se-
men analysis, routine semen analysis is 
still the cornerstone in the diagnosis of 
male infertility. The analysis is cheap to 
perform and does not require complicat-
ed instruments and procedures, though 
experienced and skillful staffs are abso-
lutely necessary for obtaining consistent 
and informative results. The new WHO 
manual provides valuable guidelines for 
the test. Andrology laboratories should 
Chart 1. Patient Management for Male Subfertility (Subfertility Clinic, QMH, HKSAR) IUI 
Should be Offered to Couples with Patient Tubes and Normal Ovulation
Normal semen parameters/mild 
male factors
(Total motile sperm > 10x10 6; 
Normal morphology >3%)
Normal semen parameters/mild 
male factors
(Normal morphology > 2%;  
Total motile sperm after washing 
>0.2x106)



























43JPOG JAN/FEB 2015CONTINUING MEDICAL EDUCATION
REFERENCES
implement quality control and quality 
assurance programs to produce reliable 
results.
Conventional semen analysis does 
not directly determine the fertilization 
capacity of the sperm. Indeed, many 
infertile male have normal semen pa-
rameters. On the other hand, subnor-
mal parameters may not necessarily 
represent infertility. Interpretation of the 
semen analysis results should be made 
together with medical history, physical 
examination and reproductive history.
Semen analysis can provide a de-
?nitive indication of infertility only in cas-
es of absolute sperm dysfunction, such 
as globozoospermia and azoospermia. 
Due to the inherent variation of semen 
samples, semen parameters do ?uc-
tuate, making consensus cut-off of the 
parameters dif?cult. Nevertheless, when 
properly performed, low percentage of 
normal sperm morphology is predictive 
of fertilization problem.
1. Hull MG, Glazener CM, Kelly NJ, et al. 
Population study of causes, treatment, and 
outcome of infertility. British medical jour-
nal. 1985;291:1693–7.
2. Irvine DS. Epidemiology and aetiology 
of male infertility. Human reproduction. 
1998;13 Suppl 1:33–44.
3. Velez de la Calle JF, Rachou E, le Mar-
telot MT, et al. Male infertility risk factors in 
a French military population. Human repro-
duction. 2001;16:481–6.
4. Bjorndahl L, Barratt CL. Semen analy-
sis: setting standards for the measurement 
of sperm numbers. Journal of andrology. 
2005;26:11.
5. World Health Organization. WHO labo-
ratory manual for the examination and pro-
cessing of human semen. 5th ed. Geneva: 
World Health Organization; 2010.
6. De Jonge C, LaFromboise M, Bosmans 
E, et al. In?uence of the abstinence period 
on human sperm quality. Fertility and steril-
ity. 2004;82:57–65.
7. Bjorndahl L, Kvist U. Sequence of ejacu-
lation affects the spermatozoon as a carrier 
and its message. Reproductive biomedi-
cine online. 2003;7:440–8.
8. Pound N, Javed MH, Ruberto C, Shaikh 
MA, Del Valle AP. Duration of sexual arous-
al predicts semen parameters for mastur-
batory ejaculates. Physiology & behavior. 
2002;76:685–9.
9. Tomlinson MJ, Naeem A, Hopkisson JF, 
Campbell B. Brief communication: assess-
ment and validation of nonspermicidal con-
doms as specimen collection sheaths for 
semen analysis and assisted conception. 
Human fertility. 2012;15:140–3.
10. Carlsen E, Petersen JH, Andersson AM, 
Skakkebaek NE. Effects of ejaculatory fre-
quency and season on variations in semen 
quality. Fertility and sterility. 2004;82:358–66.
11. van der Steeg JW, Steures P, Eijkemans 
MJ, et al. Role of semen analysis in subfertile 
couples. Fertility and sterility. 2011;95:1013–9.
12. Cooper TG, Noonan E, von Eckardstein 
S, et al. World Health Organization reference 
values for human semen characteristics. Hu-
man reproduction update. 2010;16:231–45.
13. Liu DY, Baker HW. Defective sperm-zona 
pellucida interaction: a major cause of failure 
of fertilization in clinical in-vitro fertilization. 
Human reproduction. 2000;15:702–8.
14. Guzick DS, Overstreet JW, Factor-Litvak 
P, et al. Sperm morphology, motility, and 
concentration in fertile and infertile men. 
The New England journal of medicine. 
2001;345:1388–93.
15. Zini A, Fahmy N, Belzile E, et al. An-
tisperm antibodies are not associated with 
pregnancy rates after IVF and ICSI: system-
atic review and meta-analysis. Human repro-
duction. 2011;26:1288–95.
16. National Institute for Clinical Excellence. 
Fertility: Assessment and treatment for peo-
ple with fertility problems. 2013 [Accessed 
10 Nov 2014]. Available from: http://www.
nice.org.uk/guidance/cg156.
17. Burkman LJ, Coddington CC, Franken 
DR, et al. The hemizona assay (HZA): devel-
opment of a diagnostic test for the binding of 
human spermatozoa to the human hemizona 
pellucida to predict fertilization potential. Fer-
tility and sterility. 1988;49:688–97.
18. Cummins JM, Pember SM, Jequier AM, 
Yovich JL, Hartmann PE. A test of the human 
sperm acrosome reaction following iono-
phore challenge. Relationship to fertility and 
other seminal parameters. Journal of androl-
ogy. 1991;12:98–103.
19. Barratt CL, Aitken RJ, Bjorndahl L, et al. 
Sperm DNA: organization, protection and 
vulnerability: from basic science to clinical 
applications--a position report. Human re-
production. 2010;25:824–38.
20. Practice Committee of the American Soci-
ety for Reproductive M. The clinical utility of 
sperm DNA integrity testing: a guideline. Fer-
tility and sterility. 2013;99:673–7.
21. Tomlinson M. Is your andrology service up 
to scratch? Human fertility. 2010;13:194–200.
22. Riddell D, Pacey A, Whittington K. Lack 
of compliance by UK andrology laboratories 
with World Health Organization recommen-
dations for sperm morphology assessment. 
Human reproduction. 2005;20:3441–5.
23. Franken DR, Aneck-Hahn N, Lombaard 
C, Kruger TF. Semenology training pro-
grams: 8 years’ experience. Fertility and ste-
rility. 2010;94:2615–9.
24. Bonde JP, Ernst E, Jensen TK, et al. Re-
lation between semen quality and fertility: a 
population-based study of 430 ?rst-pregnan-
cy planners. Lancet. 1998;352:1172–7.
25. Wainer R, Albert M, Dorion A, et al. In?u-
ence of the number of motile spermatozoa 
inseminated and of their morphology on the 
success of intrauterine insemination. Human 
reproduction. 2004;19:2060–5.
26. Ombelet W, Bosmans E, Janssen M, 
et al. Semen parameters in a fertile versus 
subfertile population: a need for change in 
the interpretation of semen testing. Human 
reproduction. 1997;12:987–93.
27. Campana A, Sakkas D, Stalberg A, et al. 
Intrauterine insemination: evaluation of the 
results according to the woman’s age, sperm 
quality, total sperm count per insemination 
and life table analysis. Human reproduction. 
1996;11:732–6.
28. Berg U, Brucker C, Berg FD. Effect of mo-
tile sperm count after swim-up on outcome 
of intrauterine insemination. Fertility and ste-
rility. 1997;67:747–50.
29. Stephen EH, Chandra A. Declining esti-
mates of infertility in the United States: 1982-
2002. Fertility and sterility. 2006;86:516–23.
30. von Eckardstein S, Cooper TG, Rutscha 
K, et al. Seminal plasma characteristics as 
indicators of cystic ?brosis transmembrane 
conductance regulator (CFTR) gene muta-
tions in men with obstructive azoospermia. 
Fertility and sterility. 2000;73:1226–31.
31. Weiske WH, Salzler N, Schroed-
er-Printzen I, Weidner W. Clinical ?ndings in 
congenital absence of the vasa deferentia. 
Andrologia. 2000;32:13–8.
32. Practice Committee of American Society 
for Reproductive Medicine in collaboration 
with Society for Male R, Urology. Evaluation 
of the azoospermic male. Fertility and sterili-
ty. 2008;90:S74–7.
33. Ng PP, Tang MH, Lau ET, et al. Chro-
mosomal anomalies and Y-microdeletions 
among Chinese subfertile men in Hong 
Kong. Hong Kong medical journal = Xiang-
gang yi xue za zhi / Hong Kong Academy of 
Medicine. 2009;15:31–8.
34. Dam AH, Feenstra I, Westphal JR, et al. 
Globozoospermia revisited. Human repro-
duction update. 2007;13:63–75.
35. Wolff HH, Schill WB, Moritz P. 
[Round-headed spermatozoa: a rare an-
drologic ?nding (?globe-headed spermato-
zoa?, ?globozoospermia?)]. Der Hautarzt; 
Zeitschrift fur Dermatologie, Venerologie, 
und verwandte Gebiete. 1976;27:111–6.
36. Sha YW, Ding L, Li P. Management of 
primary ciliary dyskinesia/Kartagener’s syn-
drome in infertile male patients and current 
progress in de?ning the underlying genetic 
mechanism. Asian journal of andrology. 
2014;16:101–6.
37. Tomlinson M, Lewis S, Morroll D, British 
Fertility S. Sperm quality and its relationship 
to natural and assisted conception: British 
Fertility Society guidelines for practice. Hu-
man fertility. 2013;16:175–93.
38. Grow DR, Oehninger S, Seltman HJ, et al. 
Sperm morphology as diagnosed by strict 
criteria: probing the impact of teratozoo-
spermia on fertilization rate and pregnancy 
outcome in a large in vitro fertilization popu-
lation. Fertility and sterility. 1994;62:559–67.
39. Obara H, Shibahara H, Tsunoda H, et al. 
Prediction of unexpectedly poor fertilization 
and pregnancy outcome using the strict cri-
teria for sperm morphology before and after 
sperm separation in IVF-ET. International 
journal of andrology. 2001;24:102–8.
40. Hotaling JM, Smith JF, Rosen M, Muller 
CH, Walsh TJ. The relationship between 
isolated teratozoospermia and clinical preg-
nancy after in vitro fertilization with or without 
intracytoplasmic sperm injection: a system-
atic review and meta-analysis. Fertility and 
sterility. 2011;95:1141–5.
41. College of American Pathologists. Pro?-
ciency Testing 2015. [Accessed 9 Jan 2015]. 
Available from: http://www.cap.org/web/
home/lab/pro?ciency-testing.
42. World Health Organization. WHO labo-
ratory manual for the examination of human 
semen and sperm-cervical mucus interac-
tion. 4th ed. Cambridge: Published on behalf 
of the World Health Organization by Cam-
bridge University Press; 1999.
43. Franken DR. How accurate is sperm mor-
phology as an indicator of sperm function? 
Andrologia. 2014.
44 JPOG JAN/FEB 2015 CME QUESTIONS
CME ARTICLE 
Semen Analysis – What a Clinician 
Should Know
Answer True or False to the questions below.
1.  Approximately one out of ?ve subfertile couples are affected by pure male factor 
infertility. 
2.  Patient should refrain from any sexual activities for as long as possible before 
submitting a semen sample for analysis. 
3. Patients are not allowed to collect the semen at home. 
4.  The WHO lower reference limit is derived from data collected from both the fertile 
and subfertile populations. 
5.  A man with semen parameters that fall below the WHO lower reference limit can 
still father a child. 
6. A routine semen analysis can predict the fertilization potential of sperm. 
7.  The latest edition of WHO semen analysis manual classi?es sperm mortility into 
four categories. 
8.  Kartagener’s syndrome is characterized by round-headed sperm without an 
acrosome. 
9. Semen samples from the same patient may have very different semen parameters 
10. Sperm DNA integrity test is not recommended. 
True False
This continuing medical education service is brought to you by MIMS. Read the article 
‘Semen Analysis – What a Clinician Should Know’ and answer the following questions.  
We hope you enjoy learning with JPOG.
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HKCOG CME Article: Management of Venous 
Thromboembolism in Pregnancy
Answers
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